Exelixis Inc (NAS:EXEL)
$ 36.115 0.265 (0.74%) Market Cap: 10.31 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.15 PB Ratio: 4.54 GF Score: 91/100

Exelixis Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 15, 2022 / 06:00PM GMT
Release Date Price: $20.3 (-1.41%)
Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst

Hello, everyone, and welcome to Oppenheimer's 32nd Annual Healthcare Conference. I'm Jay Olson, 1 of the biotech analysts at Oppenheimer, and I want to thank you for joining us here today. It's my pleasure to welcome Exelixis to our conference, and it's an honor to introduce Michael Morrissey, President and CEO. Thank you so much, Michael, for joining us here today. It's really a pleasure to catch up with you.

I want to remind our audience that if they have any questions during the discussion, they can please feel free to submit them using the Q&A function. And with that, we'll go ahead and get started. I thought maybe we could open up with a focus on cabo. It's a great year...

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Sounds good.

Questions & Answers

Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst

It was a great year,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot